Curanex Pharmaceuticals Inc Common Stock (CURX) vs NeuroSense Therapeutics Ltd. (NRSN)

A side-by-side comparison of Curanex Pharmaceuticals Inc Common Stock and NeuroSense Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Curanex Pharmaceuticals Inc Common Stock logo
CURX
Curanex Pharmaceuticals Inc Common Stock
$7M
$4.99HealthcareDelayed quote: Oct 6, 2026, 3:21 PM EDT
NeuroSense Therapeutics Ltd. logo
NRSN
NeuroSense Therapeutics Ltd.
$7M
$3.93HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT

Total return — CURX vs NRSN

growth of $100 · dividends reinvested · last 1y
CURX -93.8% (-93.8%/yr)NRSN -82.0% (-82.0%/yr)NRSN compounded faster over this window
050100150200Start $1002026$6$18
CURX NRSN

CURX vs NRSN: by the numbers

  • •CURX is the larger company ($7M vs $7M market cap).

Metrics side by side

Valuation

MetricCURXNRSN
P/B ratio1.48N/A

Profitability

MetricCURXNRSN
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-218.65%N/A
ROIC-208.39%N/A

Go deeper

Full CURX analysisFull NRSN analysisInteractive comparison tool

Dig into the metrics

Curanex Pharmaceuticals Inc Common Stock ROENeuroSense Therapeutics ROECuranex Pharmaceuticals Inc Common Stock operating marginNeuroSense Therapeutics operating marginCuranex Pharmaceuticals Inc Common Stock revenue growthNeuroSense Therapeutics revenue growthCuranex Pharmaceuticals Inc Common Stock free cash flowNeuroSense Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.